TR201903899T4 - Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim. - Google Patents
Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim. Download PDFInfo
- Publication number
- TR201903899T4 TR201903899T4 TR2019/03899T TR201903899T TR201903899T4 TR 201903899 T4 TR201903899 T4 TR 201903899T4 TR 2019/03899 T TR2019/03899 T TR 2019/03899T TR 201903899 T TR201903899 T TR 201903899T TR 201903899 T4 TR201903899 T4 TR 201903899T4
- Authority
- TR
- Turkey
- Prior art keywords
- iron
- solid composition
- present
- containing solid
- iron deficiency
- Prior art date
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title abstract 4
- 206010022971 Iron Deficiencies Diseases 0.000 title abstract 3
- 239000008247 solid mixture Substances 0.000 title abstract 3
- 229910052742 iron Inorganic materials 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Mevcut buluş, toplam veya göreceli demir eksikliği durumlarında kullanıma yönelik bir demir bazlı bileşim ile ilgilidir. Özellikle, mevcut buluş, demir eksikliği ile ilgili veya bu eksiklikten türetilen bozuklukların veya hastalıkların tedavisinde kullanıma yönelik tercihen toz veya granül formunda bir katı bileşim ile ilgilidir. Mevcut buluşun bileşimi, pediyatrik sujeler, ergenler, atletler, erkekler, kadınlar, hamile kadın ve yaşlı insanlar için uygundur. Son olarak, mevcut buluş, söz konusu katı bileşimin hazırlanmasına yönelik bir proses ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001350A ITMI20121350A1 (it) | 2012-07-31 | 2012-07-31 | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201903899T4 true TR201903899T4 (tr) | 2019-04-22 |
Family
ID=46982695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/03899T TR201903899T4 (tr) | 2012-07-31 | 2013-07-30 | Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim. |
Country Status (24)
Country | Link |
---|---|
US (2) | US10183077B2 (tr) |
EP (2) | EP3498265B1 (tr) |
JP (1) | JP6232426B2 (tr) |
CN (2) | CN111265546A (tr) |
BR (2) | BR122022015143B1 (tr) |
CA (1) | CA2879681C (tr) |
CY (2) | CY1121435T1 (tr) |
DK (2) | DK3498265T3 (tr) |
EA (1) | EA027684B1 (tr) |
ES (2) | ES2719252T3 (tr) |
HR (2) | HRP20190461T1 (tr) |
HU (2) | HUE052036T2 (tr) |
IL (2) | IL236793A0 (tr) |
IN (1) | IN2015MN00127A (tr) |
IT (1) | ITMI20121350A1 (tr) |
LT (2) | LT3498265T (tr) |
MA (1) | MA20150375A1 (tr) |
ME (1) | ME03349B (tr) |
PL (2) | PL3498265T3 (tr) |
PT (2) | PT3498265T (tr) |
RS (2) | RS58647B1 (tr) |
SI (2) | SI3498265T1 (tr) |
TR (1) | TR201903899T4 (tr) |
WO (1) | WO2014009806A1 (tr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20121350A1 (it) | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
ITMI20131483A1 (it) * | 2013-09-09 | 2015-03-10 | Alesco Srl | Composizioni in forma solida a base di minerali e formulazioni orosolubili contenenti le stesse. |
JP6299689B2 (ja) * | 2014-07-24 | 2018-03-28 | 三生医薬株式会社 | 生体吸収促進剤含有組成物 |
JP6459129B2 (ja) * | 2015-04-13 | 2019-01-30 | 富田製薬株式会社 | ピロリン酸第二鉄含有粉末及びその製造方法 |
WO2017090198A1 (ja) * | 2015-11-27 | 2017-06-01 | 太陽化学株式会社 | 鉄含有粉末組成物 |
IT201700085412A1 (it) * | 2017-07-26 | 2019-01-26 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
IT201700089258A1 (it) * | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
IT201800006288A1 (it) * | 2018-06-13 | 2019-12-13 | Composizioni comprendenti minerali sucrosomiali contenenti sali minerali per uso nelle condizioni di deficienza di tali minerali | |
IT201900020300A1 (it) | 2019-11-04 | 2021-05-04 | Alesco Srl | Uso di berberina sucrosomiale® e sue composizioni nel trattamento di dislipidemie |
IT201900020316A1 (it) | 2019-11-04 | 2021-05-04 | Alesco Srl | Uso di berberina sucrosomiale® e sue composizioni nel trattamento di alterazioni del metabolismo glucidico |
IT201900020290A1 (it) | 2019-11-04 | 2021-05-04 | Alesco Srl | Berberina sucrosomiale®, sue composizioni e loro uso |
IT201900021564A1 (it) * | 2019-11-19 | 2021-05-19 | Neilos S R L | Composizione nutraceutica o farmaceutica comprendente ferro pirofosfato per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie caratterizzate da carenza di ferro |
IT201900023016A1 (it) | 2019-12-04 | 2021-06-04 | Alesco Srl | Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale |
IT201900022989A1 (it) | 2019-12-04 | 2021-06-04 | Alesco Srl | Formulazione in forma solida di cromo, sue composizioni e usi |
WO2022118274A1 (en) * | 2020-12-03 | 2022-06-09 | Neilos S.r.l. | Compositions for the use in the treatment and/or prevention of iron deficiency conditions or diseases |
IT202100005981A1 (it) | 2021-03-12 | 2022-09-12 | Pharmanutra S P A | Composizione a base di ferro per uso in un trattamento di una infiammazione gastrointestinale in soggetti sottoposti ad un trattamento di una deficienza di ferro |
IT202100011084A1 (it) | 2021-04-30 | 2022-10-30 | Pharmanutra S P A | Composizione nutraceutica per uso nel trattamento della stanchezza cronica/fatigue post covid-19 |
WO2023033750A1 (en) * | 2021-08-30 | 2023-03-09 | Ilko Ilac Sanayi Ve Ticaret A.S. | Preservative free liquid formulation of lipozomal iron |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0927025A4 (en) * | 1996-09-18 | 2001-07-25 | Dragoco Inc | DRY POWDER COMPOSITION WITH ACTIVE INGREDIENT ENCLOSED IN LIPOSOMES |
US6074675A (en) | 1996-10-03 | 2000-06-13 | Taiyo Kagaku Co., Ltd. | Mineral composition |
JP2000300213A (ja) * | 1999-04-21 | 2000-10-31 | Taiyo Kagaku Co Ltd | ミネラル組成物及びミネラル強化飲食品 |
US6521247B1 (en) * | 1999-08-13 | 2003-02-18 | Warner Chilcott Laboratories Ireland Limited | Dual iron containing nutritional supplement |
JP2007224054A (ja) * | 2004-02-02 | 2007-09-06 | Taiyo Kagaku Co Ltd | 鉄組成物 |
JP4627999B2 (ja) * | 2004-02-27 | 2011-02-09 | 太陽化学株式会社 | 坑酸化剤 |
WO2005082167A1 (en) * | 2004-02-27 | 2005-09-09 | Taiyo Kagaku Co., Ltd. | Minera-containing composition and method of use thereof |
JP2006340612A (ja) * | 2005-06-07 | 2006-12-21 | Taiyo Kagaku Co Ltd | ミネラル強化用組成物 |
JP2006340613A (ja) * | 2005-06-07 | 2006-12-21 | Taiyo Kagaku Co Ltd | 鉄強化用組成物 |
JP4738410B2 (ja) * | 2005-06-22 | 2011-08-03 | 太陽化学株式会社 | 鉄強化用組成物 |
CA2634751C (en) * | 2005-12-23 | 2017-10-31 | Ajay Gupta | Parenteral nutrition composition containing iron |
JP4673235B2 (ja) * | 2006-02-16 | 2011-04-20 | 太陽化学株式会社 | 鉄強化食品用組成物 |
CA2664406A1 (en) * | 2006-09-28 | 2008-04-03 | Bayer Consumer Care Ag | Mixture of iron and copper salts masking metallic taste |
CA2802184C (en) * | 2010-06-09 | 2019-01-08 | Emisphere Technologies, Inc. | Oral iron deficiency therapy |
US20120288531A1 (en) * | 2011-01-14 | 2012-11-15 | Shmuel Tuvia | pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
ITMI20121350A1 (it) | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
US9594814B2 (en) | 2012-09-07 | 2017-03-14 | Splunk Inc. | Advanced field extractor with modification of an extracted field |
-
2012
- 2012-07-31 IT IT001350A patent/ITMI20121350A1/it unknown
-
2013
- 2013-07-30 BR BR122022015143-4A patent/BR122022015143B1/pt active IP Right Grant
- 2013-07-30 DK DK19151902.4T patent/DK3498265T3/da active
- 2013-07-30 CN CN202010086252.6A patent/CN111265546A/zh active Pending
- 2013-07-30 ES ES13777110T patent/ES2719252T3/es active Active
- 2013-07-30 CN CN201380040500.1A patent/CN104602674A/zh active Pending
- 2013-07-30 IN IN127MUN2015 patent/IN2015MN00127A/en unknown
- 2013-07-30 CA CA2879681A patent/CA2879681C/en active Active
- 2013-07-30 TR TR2019/03899T patent/TR201903899T4/tr unknown
- 2013-07-30 EP EP19151902.4A patent/EP3498265B1/en active Active
- 2013-07-30 WO PCT/IB2013/001659 patent/WO2014009806A1/en active Application Filing
- 2013-07-30 LT LTEP19151902.4T patent/LT3498265T/lt unknown
- 2013-07-30 LT LTEP13777110.1T patent/LT2879667T/lt unknown
- 2013-07-30 BR BR112015002072-0A patent/BR112015002072B1/pt active IP Right Grant
- 2013-07-30 JP JP2015524859A patent/JP6232426B2/ja active Active
- 2013-07-30 ES ES19151902T patent/ES2830428T3/es active Active
- 2013-07-30 US US14/417,786 patent/US10183077B2/en active Active
- 2013-07-30 HU HUE19151902A patent/HUE052036T2/hu unknown
- 2013-07-30 ME MEP-2019-76A patent/ME03349B/me unknown
- 2013-07-30 HU HUE13777110A patent/HUE042698T2/hu unknown
- 2013-07-30 MA MA37814A patent/MA20150375A1/fr unknown
- 2013-07-30 SI SI201331815T patent/SI3498265T1/sl unknown
- 2013-07-30 EA EA201590204A patent/EA027684B1/ru unknown
- 2013-07-30 SI SI201331383T patent/SI2879667T1/sl unknown
- 2013-07-30 RS RS20190389A patent/RS58647B1/sr unknown
- 2013-07-30 PL PL19151902T patent/PL3498265T3/pl unknown
- 2013-07-30 PT PT191519024T patent/PT3498265T/pt unknown
- 2013-07-30 EP EP13777110.1A patent/EP2879667B1/en active Active
- 2013-07-30 DK DK13777110.1T patent/DK2879667T3/en active
- 2013-07-30 PT PT13777110T patent/PT2879667T/pt unknown
- 2013-07-30 RS RS20201271A patent/RS61069B1/sr unknown
- 2013-07-30 PL PL13777110T patent/PL2879667T3/pl unknown
-
2015
- 2015-01-19 IL IL236793A patent/IL236793A0/en active IP Right Grant
-
2018
- 2018-12-11 US US16/216,432 patent/US10765752B2/en active Active
-
2019
- 2019-03-08 HR HRP20190461TT patent/HRP20190461T1/hr unknown
- 2019-03-15 CY CY20191100311T patent/CY1121435T1/el unknown
- 2019-03-24 IL IL265561A patent/IL265561B/en active IP Right Grant
-
2020
- 2020-11-06 CY CY20201101049T patent/CY1123610T1/el unknown
- 2020-11-11 HR HRP20201802TT patent/HRP20201802T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201903899T4 (tr) | Demir eksikliği durumlarında kullanıma yönelik demir içeren katı bileşim. | |
WO2015031808A3 (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
IN2015DN02826A (tr) | ||
IN2014DN08761A (tr) | ||
MX356802B (es) | Marcadores biologicos para identificar pacientes para tratamiento con antagonistas de vegf. | |
MX2015002289A (es) | Anticuerpos humanos para gfr alfa 3 y métodos para su uso. | |
PH12014502577A1 (en) | Compositions comprising an anti-pdgf aptamer and a vegf antagonist | |
MY165086A (en) | Formulations of rifaximin and uses thereof | |
MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
GB201109238D0 (en) | Antibodies | |
PH12015500610B1 (en) | Oral care composition | |
MX2015005732A (es) | Compuestos tricíclicos y métodos para hacer y utilizar los mismos. | |
MX336204B (es) | Una composicion y uso de la misma en el tratamiento de ragades anales. | |
NZ631639A (en) | Methods and compositions for treating and diagnosing acute myocardial infarction | |
IN2014DN09437A (tr) | ||
EA201290740A1 (ru) | Колготки с асимметричной торсовой частью | |
NZ596218A (en) | Bssl antagonists for treatment of inflammatory diseases | |
MX2015009549A (es) | Composicion para el cuidado de la piel. | |
AU344178S (en) | Women's fashion clothing | |
AU344179S (en) | Women's fashion clothing | |
AU344180S (en) | Women's fashion clothing | |
AU344181S (en) | Women's fashion clothing | |
AU344177S (en) | Women's fashion clothing | |
AU344182S (en) | Women's fashion clothing | |
AU344185S (en) | Women's fashion clothing |